Update on Ozempic availability – February 2023 16 February 2023 The Therapeutic Goods Administration (TGA) has advised that limited supplies of Ozempic have now arrived in Australia. It is expected that from late next week some pharmacies will have stock. The TGA expects supply to improve over the next few weeks, however stock will remain limited for some time. Health professionals are being strongly recommended to prioritise people living with type 2 diabetes and consider alternative medicines to treat people living with obesity until stock levels approve. If you live with type 2 diabetes and were using Ozempic to manage your condition talk to your pharmacist so that they can assist you in filling your prescription when they have stock. More information is available on the TGA website: https://www.tga.gov.au/news/news/limited-ozempic-supplies-commence-distribution-australia
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
Blog 27 May 2026 How diabetes, depression, anxiety, and medicines are connected People with diabetes can be depressed or anxious more often than people without diabetes. Studies show that when you have diabetes, you are almost twice as likely to be depressed, regardless of the type of diabetes. Continue Reading
